Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Xavier Sáez-Llorens"'
Autor:
Roberto Debbag, María L. Ávila-Agüero, José Brea, Helena Brenes-Chacon, Manuel Colomé, Rodrigo de Antonio, Alejandro Díaz-Díaz, Luiza Helena Falleiros-Arlant, Gerardo Fernández, Angela Gentile, Iván Felipe Gutiérrez, Daniel Jarovsky, María del Valle Juárez, Eduardo López-Medina, Abiel Mascareñas, Sebastián Ospina-Henao, Marco A. Safadi, Xavier Sáez-Llorens, Alejandra Soriano-Fallas, Juan P. Torres, Carlos N. Torres-Martínez, Claudia Beltrán-Arroyave
Publikováno v:
Frontiers in Pediatrics, Vol 12 (2024)
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in children around the world. The post-pandemic era has resulted in a notable increase in reported cases of RSV infections, co-circulation of other respirato
Externí odkaz:
https://doaj.org/article/dd463a114ff14c4baa28f9f29b1ecc3c
Autor:
Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, Carlos R. Celis, Rubelio Cornejo, Rodrigo DeAntonio, Lucie Ecker, Diegi Garrido, Ana I. Gil, Marina Gonzales, Morgan Hess-Holtz, Geert Leroux-Roels, Helga Junker, Sarah-Katharina Kays, Sven D. Koch, Sandra Lazzaro, Philipp Mann, Gianluca Quintini, Barkha Srivastava, Dominik Vahrenhorst, Philipp von Eisenhart-Rothe, Olaf-Oliver Wolz, Lidia Oostvogels
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100307- (2023)
Externí odkaz:
https://doaj.org/article/b348038516694a90b653418856f6e575
Autor:
Rahnuma Wahid, Laina Mercer, Chris Gast, Tirza De Leon, Xavier Sáez-Llorens, Alan Fix, Andrew Macadam, Laura Stephens, Konstantin Chumakov, Saskia L. Smits, Marta Murreddu, Jennifer L. Konopka-Anstadt, M. Steven Oberste, Cara C. Burns, Raul Andino, Novilia Sjafri Bachtiar, Erman Tritama, Ananda S. Bandyopadhyay, Gabriela Aguirre, Ricardo Rüttimann, John O. Konz
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-11 (2022)
Abstract Novel oral poliovirus vaccine type 2 (nOPV2) is being developed to reduce the rare occurrence of disease and outbreaks associated with the genetic instability of the Sabin vaccine strains. Children aged 1 to 5 years were enrolled in two rela
Externí odkaz:
https://doaj.org/article/a5bc437be7da4f459a47f98cae18af83
Autor:
Pio López, Eduardo López-Medina, Xavier Sáez-Llorens, Rodrigo deAntonio, Taisei Masuda, Paul M. Mendelman, James Sherwood, Frank Baehner, Astrid Borkowski
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
We conducted a dose-finding phase 2 study of the HilleVax bivalent virus-like particle (VLP) vaccine candidate (HIL-214) in two cohorts of children, 6–≤12 months and 1–≤4 years of age (N = 120 per cohort), in Panama and Colombia (ClinicalTria
Externí odkaz:
https://doaj.org/article/8bdc7287d8f147359bc3a2bc68a345d5
Autor:
Xavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, Carlos R. Celis, Rubelio Cornejo, Rodrigo DeAntonio, Lucie Ecker, Diegi Garrido, Ana I. Gil, Marina Gonzales, Morgan Hess-Holtz, Geert Leroux-Roels, Helga Junker, Sarah-Katharina Kays, Sven D. Koch, Sandra Lazzaro, Philipp Mann, Gianluca Quintini, Barkha Srivastava, Dominik Vahrenhorst, Philipp von Eisenhart-Rothe, Olaf-Oliver Wolz, Lidia Oostvogels
Publikováno v:
Vaccine: X, Vol 11, Iss , Pp 100189- (2022)
Background: The COVID-19 vaccine candidate CVnCoV comprises sequence-optimized mRNA encoding SARS-CoV-2 S-protein encapsulated in lipid nanoparticles. In this phase 2a study, we assessed reactogenicity and immunogenicity of two or three doses in youn
Externí odkaz:
https://doaj.org/article/d56f1f88b42c415798b797e7768908f9
Autor:
Alcibiades Villarreal, Giselle Rangel, Xu Zhang, Digna Wong, Gabrielle Britton, Patricia L. Fernandez, Ambar Pérez, Diana Oviedo, Carlos Restrepo, María B. Carreirra, Dilcia Sambrano, Gilberto A. Eskildsen, Carolina De La Guardia, Julio Flores-Cuadra, Jean-Paul Carrera, Yamitzel Zaldivar, Danilo Franco, Sandra López-Vergès, Dexi Zhang, Fangjing Fan, Baojun Wang, Xavier Sáez-Llorens, Rodrigo DeAntonio, Ivonne Torres-Atencio, Isabel Blanco, Fernando Diaz Subía, Laiss Mudarra, Aron Benzadon, Walter Valverde, Lineth López, Nicolás Hurtado, Neyla Rivas, Julio Jurado, Aixa Carvallo, Juan Rodriguez, Yaseikiry Perez, Johanna Morris, Odemaris Luque, David Cortez, Eduardo Ortega-Barria, Rao Kosagisharaf, Ricardo Lleonart, Chong Li, Amador Goodridge
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in 1 year. The serological detection of antibodies aga
Externí odkaz:
https://doaj.org/article/aa97be51f8f54ba6a671e9e54778ce37
Autor:
Xavier Sáez-Llorens, Johnny Beltran-Rodriguez, Jose M. Novoa Pizarro, Ilhem Mensi, Pavitra Keshavan, Daniela Toneatto
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 5, Pp 1161-1174 (2018)
This open-label, multicenter extension study (NCT02451514) assessed persistence of Neisseria meningitidis serogroups ABCWY antibodies 4 years after primary vaccination. Adolescents and young adults who previously received 2 doses of MenABCWY+OMV (Gro
Externí odkaz:
https://doaj.org/article/4322e65087f54ab1ab1f0cf217807a98
Autor:
Shabir A. Madhi, Luis M. Rivera, Xavier Sáez-Llorens, Clara Menéndez, Nazira Carrim-Ganey, Mark F. Cotton, Darren Katzman, Mariëtha M. Luttig, Rosalba Candelario, Sherryl Baker, Mahua Roychoudhury
Publikováno v:
BMC Pregnancy and Childbirth, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background The successful implementation of maternal vaccination relies on results of clinical trials, considering the prenatal and postnatal attendance at selected healthcare institutions. This study evaluated factors influencing maternal/i
Externí odkaz:
https://doaj.org/article/113c3475364f41d596317bdb9a23a4d2
Autor:
Xavier Sáez-Llorens, Stella Rowley, Digna Wong, Mirna Rodríguez, Arlene Calvo, Marisol Troitiño, Albino Salas, Vielka Vega, Maria Mercedes Castrejón, Patricia Lommel, Thierry G. Pascal, William P. Hausdorff, Dorota Borys, Javier Ruiz-Guiñazú, Eduardo Ortega-Barría, Juan Pablo Yarzabal, Lode Schuerman
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 6, Pp 1213-1228 (2017)
We previously reported 10-valent pneumococcal non-typeable Haemophilus influenzae (NTHi) protein D conjugate vaccine (PHiD-CV) efficacy in a double-blind randomized trial (ClinicalTrials.gov: NCT00466947) against various diseases, including acute oti
Externí odkaz:
https://doaj.org/article/04e5966748cb419fb43a4b6fd3048e72
Autor:
Miguel W Tregnaghi, Xavier Sáez-Llorens, Pio López, Hector Abate, Enrique Smith, Adriana Pósleman, Arlene Calvo, Digna Wong, Carlos Cortes-Barbosa, Ana Ceballos, Marcelo Tregnaghi, Alexandra Sierra, Mirna Rodriguez, Marisol Troitiño, Carlos Carabajal, Andrea Falaschi, Ana Leandro, Maria Mercedes Castrejón, Alejandro Lepetic, Patricia Lommel, William P Hausdorff, Dorota Borys, Javier Ruiz Guiñazú, Eduardo Ortega-Barría, Juan P Yarzábal, Lode Schuerman, COMPAS Group
Publikováno v:
PLoS Medicine, Vol 12, Iss 6, p e1001850 (2015)
Externí odkaz:
https://doaj.org/article/1b1ed219d2ef43cc8b1c53d1581582b0